VirtualScopics offers a suite of image analysis software tools and applications that enable automated, accurate, and reproducible measurement of changes that occur in anatomic structures in musculoskeletal, oncological, cardiological, and neurological diseases. The company collaborates with sponsors to optimize imaging solutions and provide quantitative imaging data that helps detect disease progression faster and identify therapeutic benefits sooner. VirtualScopics has a strategic relationship with Pfizer Inc. for the discovery, validation, and application of image-based biomarkers for clinical research. The company's medical and scientific expertise, operational flexibility, and responsiveness are hallmarks of its daily work and collaborative approach.